Clinical Trials Sponsored by NeuroSearch A/S

Total 2511 results

Novo Nordisk A/S

Terminated

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Inflammation | Ulcerative Colitis

Poland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
H. Lundbeck A/S

Completed

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Healthy Men and Women

United Kingdom
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

United Kingdom
Novo Nordisk A/S

Completed

Observational Study on Levemir® in Obese Diabetic Patients (KILOS)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Netherlands, Slovenia
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes (IDEALS)

Diabetes Mellitus, Type 2 | Diabetes

Algeria
Novo Nordisk A/S

Completed

Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Chronic Kidney Disease | Turner Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Genetic Disorder | Delivery Systems | Foetal Growth Problem | Small for Gestational Age

France
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)

Diabetes Mellitus, Type 2 | Diabetes

Austria
H. Lundbeck A/S

Completed

Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects

Healthy Volunteers

France
H. Lundbeck A/S

Completed

Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia

Schizophrenia | Cognition

United States
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

Major Depressive Disorder
Novo Nordisk A/S

Completed

Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia (ACQUI-7)

Acquired Bleeding Disorder | Acquired Haemophilia

France
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients

Major Depressive Disorder
ALK-Abelló A/S

Completed

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (SUMMIT)

Allergic Rhinitis

France
Santaris Pharma A/S

Unknown

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Hepatitis C

Puerto Rico
H. Lundbeck A/S

Completed

Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

Parkinson's Disease
Novo Nordisk A/S

Completed

Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Novo Nordisk A/S

Terminated

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of Two Identical NN1250 Formulations in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers

Healthy | Congenital Bleeding Disorder | Congenital FXIII Deficiency

United Kingdom
Novo Nordisk A/S

Completed

A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
H. Lundbeck A/S

Completed

Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls

Depression

United Kingdom
H. Lundbeck A/S

Completed

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Dementia With Lewy Bodies | Parkinson's Disease Dementia

Germany
H. Lundbeck A/S

Completed

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence (SENSE)

Alcohol Dependence

Poland, Russian Federation, Ukraine, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Slovakia, United Kingdom
H. Lundbeck A/S

Completed

Efficacy of Nalmefene in Patients With Alcohol Dependence (ESENSE1)

Alcohol Dependence

Austria, Finland, Germany, Sweden
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy

Allergic Rhinitis Due to Olea Europaea Pollen

Spain
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
Novo Nordisk A/S

Completed

Safety and Efficacy of Insulin Aspart in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Santaris Pharma A/S

Completed

SPC3649 Multiple Dose Study in Healthy Volunteers

Hepatitis C

Netherlands
Action Pharma A/S

Completed

Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Valve Surgery | Cardiac Surgery | Coronary Artery Bypass Grafting | Aortic Root or Ascending Aortic Aneurysm Repair Surgery

Denmark
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

India, Indonesia, Korea, Republic of, Malaysia, Philippines, Poland, Ukraine
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Depression in Patients With Bipolar Disorder

Austria, Philippines, Australia, Belgium, Bulgaria, Canada, France, Germany, Korea, Republic of, Lithuania, Malaysia, Poland, Romania, Slovakia, Sweden, Taiwan, Ukraine, United Kingdom
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

Bulgaria, China, Greece, Romania, Russian Federation, Taiwan, Thailand, Ukraine
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Assessment of Grazax® Treatment Compliance

Allergy

Austria
Astion Pharma A/S

Completed

Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis

Seborrheic Dermatitis
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
Astion Pharma A/S

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

Discoid Lupus Erythematosus

Denmark
Astion Pharma A/S

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions

Discoid Lupus Erythematosus

Sweden
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia
H. Lundbeck A/S

Not yet recruiting

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease (BalanCeD)

Cushing's Disease
Novo Nordisk A/S

Recruiting

A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

Obesity

Canada
Novo Nordisk A/S

Recruiting

A Research Study of the Effect of Food on Etavopivat in Healthy Participants

Healthy Volunteers Sickle Cell Disease, Thalassemia

United States
Novo Nordisk A/S

Not yet recruiting

A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight

Obesity

United Kingdom, Germany, Canada, United States, France
Novo Nordisk A/S

Recruiting

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

Diabetes, Type 2

United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
H. Lundbeck A/S

Recruiting

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men

Healthy Participants

United Kingdom
Novo Nordisk A/S

Not yet recruiting

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Type 2 Diabetes
Novo Nordisk A/S

Recruiting

A Study of How CagriSema Works on Appetite in People With Excess Body Weight

Obesity | Overweight

Germany
Novo Nordisk A/S

Recruiting

A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight

Obesity

Germany

3

Subscribe